US approves new drug to treat Alzheimer's disease

By Agence France-Presse

Jan 07, 2023 10:18 am

THE US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

The FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticized in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

More areas under Signal No. 2 as 'Ofel' threatens NLuzon

Malacanang releases new Marcos appointees

Tropical storm forecast to enter PH as 'Ofel' whips NLuzon — Pagasa

Duterte to ICC: Hurry up with your probe

Korean actor Song Jae-rim passes away at 39; colleagues mourn

Signal No. 2 up over Cagayan, Isabela as 'Ofel' maintains strength — Pagasa

Former president Duterte arrives at House